Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

100.6K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
100.6K
Sanger Sequencing01:57

Sanger Sequencing

777.4K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
777.4K
Maxam-Gilbert Sequencing01:05

Maxam-Gilbert Sequencing

13.5K
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
13.5K
RNA-seq03:21

RNA-seq

12.4K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.4K
Genomics02:02

Genomics

41.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.6K
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

819
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
819

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Court Intrusion Into Science and Medicine-The Mifepristone Decisions.

JAMA·2023
Same author

Jurors use mental state information to assess breach in negligence cases.

Cognition·2023
Same author

Exploring the intersection of structural racism and ageism in healthcare.

Journal of the American Geriatrics Society·2022
Same author

Interpretation and reporting of large regions of homozygosity and suspected consanguinity/uniparental disomy, 2021 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG).

Genetics in medicine : official journal of the American College of Medical Genetics·2021
Same author

WHY WE FEAR GENETIC INFORMANTS: USING GENETIC GENEALOGY TO CATCH SERIAL KILLERS.

The Columbia science and technology law review·2021
Same author

Correction: Ethical and public health implications of genetic testing for suicide risk: family and survivor perspectives.

Genetics in medicine : official journal of the American College of Medical Genetics·2020
Same journal

Diversity's Pandemic Distractions.

Health matrix (Cleveland, Ohio : 1991)·2022
Same journal

The Web of Legal Protections for Participants in Genomic Research.

Health matrix (Cleveland, Ohio : 1991)·2019
Same journal

Different but Same: A Call for a Joint Pro-Active Regulation of Cross-Border Egg and Surrogacy Markets.

Health matrix (Cleveland, Ohio : 1991)·2019
Same journal

Prosecuting Women For Drug Use During Pregnancy: The Criminal Justice System Should Step Out and the Affordable Care Act Should Step Up.

Health matrix (Cleveland, Ohio : 1991)·2018
Same journal

Medicaid and Migrant Farmworkers: Why the State Residency Requirement Presents a Significant Access Barrier and What States Should Do About It.

Health matrix (Cleveland, Ohio : 1991)·2018
Same journal

"Don't Have A Cow, Man!": Recognizing Herd Share Agreements for Raw Milk.

Health matrix (Cleveland, Ohio : 1991)·2018
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons
10:24

Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons

Published on: August 29, 2014

84.8K

Needles, Haystacks and Next-Generation Genetic Sequencing.

Teneille R Brown1

  • 1† Teneille R. Brown, J.D. is a Professor of Law at the University of Utah, S.J Quinney College of Law, and an adjunct Professor of Internal Medicine in the Division of Medical Ethics and Humanities at the University of Utah.

Health Matrix (Cleveland, Ohio : 1991)
|March 16, 2026
PubMed
Summary
This summary is machine-generated.

Clinical laboratories face complex genetic testing results. While ethically obligated to share some secondary findings, they should not face tort liability for failing to disclose these incidental genetic mutations.

More Related Videos

Ultra-long Read Sequencing for Whole Genomic DNA Analysis
10:34

Ultra-long Read Sequencing for Whole Genomic DNA Analysis

Published on: March 15, 2019

24.2K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K

Related Experiment Videos

Last Updated: Mar 18, 2026

Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons
10:24

Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons

Published on: August 29, 2014

84.8K
Ultra-long Read Sequencing for Whole Genomic DNA Analysis
10:34

Ultra-long Read Sequencing for Whole Genomic DNA Analysis

Published on: March 15, 2019

24.2K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K

Area of Science:

  • Genetics
  • Bioethics
  • Medical Law

Background:

  • Genetic testing is increasingly common, yielding complex results.
  • Incidental or secondary findings can arise from genetic analyses for other purposes.
  • The American College of Medical Genetics (ACMG) recommended reporting specific, serious, treatable, and potentially undetected secondary mutations.

Purpose of the Study:

  • To analyze the scope of negligence liability for clinical laboratories regarding secondary findings.
  • To determine if laboratories should be subject to tort liability for failing to disclose secondary findings.

Main Methods:

  • Legal and ethical analysis of ACMG recommendations.
  • Examination of negligence liability principles in the context of genetic testing.

Main Results:

  • ACMG recommendations for reporting secondary findings have generated significant debate.
  • Laboratories may have ethical or professional duties to share certain genetic information.
  • The article argues against imposing tort liability on laboratories for non-disclosure of secondary findings.

Conclusions:

  • While ethical obligations exist for sharing specific secondary genetic findings, legal recourse through tort liability is not supported.
  • Distinguishing between ethical duties and legal liability is crucial for clinical laboratories.
  • The focus should be on professional guidelines rather than litigation for non-disclosure of incidental genetic information.